Latest filing published 28 Sept 2023 for Acasti Pharma Inc., €877k.
No signal scores available.
Vimal Kavuru discloses dealings in Acasti Pharma Inc. to SEDI. Over a trading history stretching from 10 July 2023 to 25 September 2023, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 28 September 2023 with a transaction (€877k) in Acasti Pharma Inc. The median gap between a trade and its publication by SEDI is 4 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations